Espinoza Octavio
Chief Financial Officer · 35 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | LGND | LIGAND PHARMACEUTICALS INC | J | 17 | $160.71 | $2,732.06 | filing |
| 2026-05-27 | LGND | LIGAND PHARMACEUTICALS INC | Option exercise | 972 | $52.84 | $51,360.48 | filing |
| 2026-05-27 | LGND | LIGAND PHARMACEUTICALS INC | Option exercise | 764 | $63.62 | $48,605.68 | filing |
| 2026-03-11 | LGND | LIGAND PHARMACEUTICALS INC | Sale | 3,057 | $225.00 | $687,825.00 | filing |
| 2026-03-11 | LGND | LIGAND PHARMACEUTICALS INC | Option exercise | 2,405 | $92.65 | $222,823.25 | filing |
| 2026-03-04 | LGND | LIGAND PHARMACEUTICALS INC | Sale | 3,413 | $208.80 | $712,620.75 | filing |
| 2026-03-04 | LGND | LIGAND PHARMACEUTICALS INC | Sale | 2,457 | $207.91 | $510,823.08 | filing |
| 2026-03-04 | LGND | LIGAND PHARMACEUTICALS INC | Sale | 1,588 | $206.89 | $328,541.96 | filing |
| 2026-03-04 | LGND | LIGAND PHARMACEUTICALS INC | Sale | 1,457 | $205.79 | $299,841.42 | filing |
| 2026-03-04 | LGND | LIGAND PHARMACEUTICALS INC | Sale | 950 | $201.73 | $191,640.27 | filing |
| 2026-03-04 | LGND | LIGAND PHARMACEUTICALS INC | Sale | 743 | $204.74 | $152,125.46 | filing |
| 2026-03-04 | LGND | LIGAND PHARMACEUTICALS INC | Sale | 697 | $202.79 | $141,342.75 | filing |
| 2026-03-04 | LGND | LIGAND PHARMACEUTICALS INC | Sale | 698 | $201.09 | $140,363.54 | filing |
| 2026-03-04 | LGND | LIGAND PHARMACEUTICALS INC | Sale | 699 | $198.71 | $138,894.93 | filing |
| 2026-03-04 | LGND | LIGAND PHARMACEUTICALS INC | Sale | 668 | $203.63 | $136,023.97 | filing |
| 2026-03-04 | LGND | LIGAND PHARMACEUTICALS INC | Option exercise | 1,607 | $58.49 | $93,993.43 | filing |
| 2026-03-04 | LGND | LIGAND PHARMACEUTICALS INC | Option exercise | 466 | $80.72 | $37,615.52 | filing |
| 2026-03-04 | LGND | LIGAND PHARMACEUTICALS INC | Sale | 53 | $200.08 | $10,604.12 | filing |
| 2026-03-02 | LGND | LIGAND PHARMACEUTICALS INC | Award | 4,933 | $0.00 | $0.00 | filing |
| 2026-02-15 | LGND | LIGAND PHARMACEUTICALS INC | Tax withholding | 1,270 | $183.83 | $233,464.10 | filing |
| 2026-02-15 | LGND | LIGAND PHARMACEUTICALS INC | Tax withholding | 1,223 | $183.83 | $224,824.09 | filing |
| 2026-02-15 | LGND | LIGAND PHARMACEUTICALS INC | Tax withholding | 1,026 | $183.83 | $188,609.58 | filing |
| 2026-02-14 | LGND | LIGAND PHARMACEUTICALS INC | Tax withholding | 4,483 | $183.83 | $824,109.89 | filing |
| 2026-02-14 | LGND | LIGAND PHARMACEUTICALS INC | Tax withholding | 3,761 | $183.83 | $691,384.63 | filing |
| 2026-02-14 | LGND | LIGAND PHARMACEUTICALS INC | Award | 7,390 | $0.00 | $0.00 | filing |
| 2026-02-14 | LGND | LIGAND PHARMACEUTICALS INC | Award | 8,810 | $0.00 | $0.00 | filing |
| 2025-12-31 | LGND | LIGAND PHARMACEUTICALS INC | J | 8 | $95.68 | $765.41 | filing |
| 2025-12-16 | LGND | LIGAND PHARMACEUTICALS INC | Option exercise | 1,194 | $52.84 | $63,090.96 | filing |
| 2025-12-16 | LGND | LIGAND PHARMACEUTICALS INC | Option exercise | 652 | $92.65 | $60,407.80 | filing |
| 2025-12-16 | LGND | LIGAND PHARMACEUTICALS INC | Option exercise | 181 | $103.42 | $18,719.02 | filing |
| 2025-12-16 | LGND | LIGAND PHARMACEUTICALS INC | Option exercise | 285 | $63.62 | $18,131.70 | filing |
| 2025-12-16 | LGND | LIGAND PHARMACEUTICALS INC | Option exercise | 69 | $57.22 | $3,948.18 | filing |
| 2025-12-12 | LGND | LIGAND PHARMACEUTICALS INC | Sale | 1,804 | $188.31 | $339,711.24 | filing |
| 2025-12-05 | LGND | LIGAND PHARMACEUTICALS INC | Tax withholding | 1,862 | $184.87 | $344,227.94 | filing |
| 2025-06-30 | LGND | LIGAND PHARMACEUTICALS INC | J | 224 | $91.08 | $20,401.36 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.